Source:http://linkedlifedata.com/resource/pubmed/id/19039946
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2008-12-1
|
| pubmed:abstractText |
Correlation between superlow-dose antibodies to endothelial NO synthase (Impaza) and serum level of ADMA was evaluated in a double blind placebo-controlled study. The reduction of ADMA in patients with erectile dysfunction after impaza treatment was paralleled by improvement of clinical symptoms. No clear-cut correlation between ADMA level and impaza effect was detected.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0007-4888
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
145
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
367-70
|
| pubmed:meshHeading |
pubmed-meshheading:19039946-Adult,
pubmed-meshheading:19039946-Antibodies,
pubmed-meshheading:19039946-Arginine,
pubmed-meshheading:19039946-Double-Blind Method,
pubmed-meshheading:19039946-Erectile Dysfunction,
pubmed-meshheading:19039946-Humans,
pubmed-meshheading:19039946-Male,
pubmed-meshheading:19039946-Nitric Oxide Synthase Type III
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Study of the correlation between clinical efficiency of impaza and serum ADMA level.
|
| pubmed:affiliation |
nauka@materiamedica.ru
|
| pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|